LV5621A3 - [3H]-imidazo-[5,1-a]-1,2,3,5-tetrazin-4-ona atvasinajumu iegusanas metode - Google Patents

[3H]-imidazo-[5,1-a]-1,2,3,5-tetrazin-4-ona atvasinajumu iegusanas metode

Info

Publication number
LV5621A3
LV5621A3 LV931303A LV931303A LV5621A3 LV 5621 A3 LV5621 A3 LV 5621A3 LV 931303 A LV931303 A LV 931303A LV 931303 A LV931303 A LV 931303A LV 5621 A3 LV5621 A3 LV 5621A3
Authority
LV
Latvia
Prior art keywords
tetrazin
imidazo
derivatives
obtaining
Prior art date
Application number
LV931303A
Other languages
English (en)
Inventor
Edward Lunt
Malcolm Francis Graham Stevens
Robert Stone
Kenneth Robert Harr Wooldridge
Original Assignee
May & Baker Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by May & Baker Ltd filed Critical May & Baker Ltd
Publication of LV5621A3 publication Critical patent/LV5621A3/lv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
LV931303A 1981-08-24 1993-12-03 [3H]-imidazo-[5,1-a]-1,2,3,5-tetrazin-4-ona atvasinajumu iegusanas metode LV5621A3 (lv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8125791 1981-08-24

Publications (1)

Publication Number Publication Date
LV5621A3 true LV5621A3 (lv) 1994-05-10

Family

ID=10524141

Family Applications (2)

Application Number Title Priority Date Filing Date
LV930621A LV5511A3 (lv) 1981-08-24 1993-06-19 Ú3H¾-imidazo-Ú5,1-a¾-1,2,3,5-tetrazin-4-ona atvasinajumu iegusanas panemiens
LV931303A LV5621A3 (lv) 1981-08-24 1993-12-03 [3H]-imidazo-[5,1-a]-1,2,3,5-tetrazin-4-ona atvasinajumu iegusanas metode

Family Applications Before (1)

Application Number Title Priority Date Filing Date
LV930621A LV5511A3 (lv) 1981-08-24 1993-06-19 Ú3H¾-imidazo-Ú5,1-a¾-1,2,3,5-tetrazin-4-ona atvasinajumu iegusanas panemiens

Country Status (29)

Country Link
JP (1) JPS5843975A (lv)
KR (1) KR890000094B1 (lv)
AT (1) AT380256B (lv)
AU (1) AU571430B2 (lv)
BE (1) BE894175A (lv)
CA (1) CA1197247A (lv)
CH (1) CH655114A5 (lv)
DE (2) DE19975037I2 (lv)
DK (1) DK161147C (lv)
ES (1) ES8400438A1 (lv)
FI (1) FI73434C (lv)
FR (1) FR2511679A1 (lv)
GB (1) GB2104522B (lv)
GE (1) GEP19960641B (lv)
GR (1) GR76863B (lv)
HU (1) HU186107B (lv)
IE (1) IE53408B1 (lv)
IL (1) IL66606A (lv)
IT (1) IT1152505B (lv)
LT (1) LT2436B (lv)
LU (1) LU84347A1 (lv)
LV (2) LV5511A3 (lv)
NL (2) NL192739C (lv)
NZ (1) NZ201668A (lv)
OA (1) OA07174A (lv)
SE (1) SE448543B (lv)
SU (1) SU1447284A3 (lv)
UA (1) UA5971A1 (lv)
ZA (1) ZA826120B (lv)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260291A (en) * 1981-08-24 1993-11-09 Cancer Research Campaign Technology Limited Tetrazine derivatives
GB2125402B (en) * 1982-08-17 1985-11-13 May & Baker Ltd New tetrazine derivatives
FR2531958B1 (fr) * 1982-08-17 1986-10-31 May & Baker Ltd Nouveaux derive
US4517182A (en) * 1983-05-24 1985-05-14 Warner-Lambert Company 3-(Haloethyl)-4-oxopyrazolo-[5,1-d]-1,2,3,5-tetrazine-8-carboxamide composition
GB8616125D0 (en) * 1986-07-02 1986-08-06 May & Baker Ltd Compositions of matter
AU622330B2 (en) * 1989-06-23 1992-04-02 Takeda Chemical Industries Ltd. Condensed heterocyclic compounds having a nitrogen atom in the bridgehead for use as fungicides
US7615632B2 (en) 2003-12-30 2009-11-10 Chemagis Ltd. Crystalline forms of temozolomide
JP5475235B2 (ja) 2005-01-21 2014-04-16 アステックス・セラピューティクス・リミテッド 医薬化合物
PE20080695A1 (es) 2006-04-27 2008-06-28 Banyu Pharma Co Ltd Derivados de dihidropirazolopirimidinona como inhibidores de quinasa weel
JP2008081492A (ja) 2006-08-31 2008-04-10 Banyu Pharmaceut Co Ltd オーロラａ選択的阻害作用を有する新規アミノピリジン誘導体
EP2073803B1 (en) 2006-10-12 2018-09-19 Astex Therapeutics Limited Pharmaceutical combinations
US8883790B2 (en) 2006-10-12 2014-11-11 Astex Therapeutics Limited Pharmaceutical combinations
JPWO2009054332A1 (ja) 2007-10-23 2011-03-03 萬有製薬株式会社 ピリドン置換ジヒドロピラゾロピリミジノン誘導体
PE20091101A1 (es) * 2007-12-18 2009-07-26 Pharminox Ltd AMIDAS DE ACIDO 3-SUBSTITUIDO-4-OXO-3,4-DIHIDRO-IMIDAZO[5,1-d] [1,2,3,5-TETRACINA-8-CARBOXILICO Y SU EMPLEO
CA2744560A1 (en) * 2008-11-24 2010-05-27 Reliance Life Sciences Pvt. Ltd. Process for the preparation of tetrazine derivatives
US8481503B2 (en) 2009-03-06 2013-07-09 Merck Sharp & Dohme Corp. Combination cancer therapy with an AKT inhibitor and other anticancer agents
JP2012530775A (ja) 2009-06-23 2012-12-06 ファーミノックス リミテッド ３−置換−８−置換−３Ｈ−イミダゾ［５，１−ｄ］［１，２，３，５−テトラジン−４−オン化合物及びその使用
RU2462466C1 (ru) * 2011-06-24 2012-09-27 Автономная Некоммерческая Организация "Научно-Исследовательский Центр Биотехнологии Антибиотиков И Других Биологически Активных Веществ "Биоан" Замещенные азоло[1,2,4,5]тетразины - ингибиторы актинобактериальных серин-треониновых протеинкиназ
EP2766041B1 (en) 2011-10-12 2018-12-05 Children's Medical Center Corporation Combinatorial compositions and methods of treating hemoglobinopathies
KR20230042756A (ko) 2016-03-15 2023-03-29 오리존 지노믹스 에스.에이. 고형 종양의 치료에 사용하기 위한 lsd1 억제제의 조합물
KR101847342B1 (ko) * 2017-05-08 2018-04-11 (주)센텍코리아 웨어러블 체지방 연소량 측정기

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2932305A1 (de) * 1979-08-09 1981-02-26 Basf Ag Azolo- eckige klammer auf 5,1-d eckige klammer zu - eckige klammer auf 1,2,3,5 eckige klammer zu -tetrazin-4-one und verfahren zur herstellung dieser verbindungen

Also Published As

Publication number Publication date
KR890000094B1 (ko) 1989-03-07
LV5511A3 (lv) 1994-03-10
OA07174A (fr) 1984-04-30
IE53408B1 (en) 1988-11-09
NL990010I2 (nl) 1999-09-01
NL8203286A (nl) 1983-03-16
FI822921L (fi) 1983-02-25
ES515176A0 (es) 1983-11-01
DE19975037I2 (de) 2001-06-13
GB2104522B (en) 1985-06-12
LU84347A1 (fr) 1983-06-07
DK377882A (da) 1983-02-25
GB2104522A (en) 1983-03-09
CH655114A5 (fr) 1986-03-27
IT8222938A0 (it) 1982-08-23
NL192739C (nl) 1998-01-06
NZ201668A (en) 1985-08-16
DE3231255A1 (de) 1983-03-03
LT2436B (lt) 1994-02-15
IE822026L (en) 1983-02-24
AU571430B2 (en) 1988-04-21
JPS5843975A (ja) 1983-03-14
FI73434B (fi) 1987-06-30
SE8204817D0 (sv) 1982-08-23
UA5971A1 (uk) 1994-12-29
HU186107B (en) 1985-06-28
FR2511679B1 (lv) 1985-02-01
DK161147B (da) 1991-06-03
ZA826120B (en) 1983-07-27
JPH045029B2 (lv) 1992-01-30
SU1447284A3 (ru) 1988-12-23
NL192739B (nl) 1997-09-01
DE3231255C2 (lv) 1992-02-27
FI73434C (fi) 1987-10-09
SE448543B (sv) 1987-03-02
DK161147C (da) 1991-11-18
AT380256B (de) 1986-05-12
FR2511679A1 (fr) 1983-02-25
GEP19960641B (en) 1996-11-15
ES8400438A1 (es) 1983-11-01
SE8204817L (sv) 1983-02-25
IL66606A (en) 1987-07-31
FI822921A0 (fi) 1982-08-23
AU8749382A (en) 1983-03-03
IT1152505B (it) 1987-01-07
IL66606A0 (en) 1982-12-31
GR76863B (lv) 1984-09-04
BE894175A (fr) 1983-02-23
ATA319182A (de) 1985-09-15
CA1197247A (fr) 1985-11-26
NL990010I1 (nl) 1999-07-01
KR840001175A (ko) 1984-03-28

Similar Documents

Publication Publication Date Title
LV5621A3 (lv) [3H]-imidazo-[5,1-a]-1,2,3,5-tetrazin-4-ona atvasinajumu iegusanas metode
ES543654A0 (es) Metodo de obtener derivados de 1,4-dihidropiridinas
NO844845L (no) Derivater av 2,2`-iminobisetanol
NO821087L (no) Fremgangsmaate for fremstilling av cyklobutan-derivater.
IT1150897B (it) Procedimento per la fabbricazione di vulcanizzati
IT1152146B (it) Procedimento per la produzione di nerofumo
RO84584A (ro) Procedeu pentru prepararea unor derivati de benzotiofen
DE3262342D1 (de) 7-deazapurine derivatives
MC1490A1 (fr) Derives de morphinane
ES517862A0 (es) Derivados de alcanosulfonanilida.
ES512519A0 (es) Proceso de fabricacion de los nuevos derivados de la amidinopiperadina.
NO823637L (no) Fremgangsmaate for fremstilling av eburnamoninderivater
NO822634L (no) Fremgangsmaate for fremstilling av cefemderivater.
ES511220A0 (es) "procedimiento de preparacion de nuevos derivados 4-aminoetoxi-5-isopropil-2-metil".
IT1154275B (it) Procedimento per la produzione di disolfuri di tiurame
RO85070A (ro) Procedeu pentru prepararea unor derivati de n-fenil-carbamati
ES511174A0 (es) Proceso de produccion de los derivados de la piperacina.
FI821816A0 (fi) Framstaellning av xantan med laog pyruvat-halt
BE892516A (fr) Derives de la thiazolidine
DE3270127D1 (de) Imidazoline derivatives
NO820767L (no) Fremgangsmaate for fremstilling av tetrahydropyridinderivater
ES517428A0 (es) Procedimiento de preparacion de derivados bencilidenicos.
ES526647A0 (es) Metodo de preparar derivados de p-acilaminofenol
FR2497800B1 (fr) Nouveaux derives de nitrosouree
FR2601009B1 (fr) Derives de cyclohexanone